Abstract
Polyunsaturated fatty acids (PUFAs) are known to suppress inflammatory and autoimmune responses and, therefore, clinical applications of PUFAs as immunomodulatory substances are extensively studied. PUFAs are known to inhibit T cell responses, but with respect to TCR/CD3-mediated signal transduction only a block in CD3-induced phospholipase Cgamma1/calcium signaling has been shown so far. In this study, we investigated PUFA-mediated changes in downstream T cell signal transduction. We show that among the mitogen-activated protein kinase families activation of c-Jun NH(2)-terminal kinase, but not phosphorylation of extracellular signal-regulated kinase-1/-2 or p38 is inhibited. CD3/CD28-induced activity of NF-AT was markedly reduced by PUFA treatment, while activation of other nuclear receptors (AP-1 and NF-kappaB) remained unaltered. Furthermore, IL-2 promoter activity, IL-2 and IL-13 mRNA levels, IL-2 secretion, and IL-2R alpha-chain expression were significantly diminished by PUFA treatment, whereas the expression of IFN-gamma, IL-4, IL-10, and CD69 remained essentially unaffected by PUFAs. In conclusion, PUFA treatment of T cells inhibits selectively c-Jun NH(2)-terminal kinase and NF-AT activation, resulting in diminished production of IL-2 and IL-13.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adjuvants, Immunologic / pharmacology
-
Down-Regulation / drug effects
-
Down-Regulation / immunology
-
Enzyme Activation / drug effects
-
Enzyme Activation / immunology
-
Fatty Acids, Unsaturated / pharmacology*
-
Humans
-
Immunosuppressive Agents / pharmacology*
-
Interleukin-13 / antagonists & inhibitors
-
Interleukin-13 / biosynthesis
-
Interleukin-2 / antagonists & inhibitors
-
Interleukin-2 / biosynthesis
-
JNK Mitogen-Activated Protein Kinases
-
Jurkat Cells
-
Lymphocyte Activation / drug effects
-
Mitogen-Activated Protein Kinases / antagonists & inhibitors*
-
Mitogen-Activated Protein Kinases / metabolism
-
NF-kappa B / antagonists & inhibitors*
-
NF-kappa B / metabolism
-
Protein Subunits / antagonists & inhibitors
-
Protein Subunits / biosynthesis
-
Receptors, Interleukin-2 / antagonists & inhibitors
-
Receptors, Interleukin-2 / biosynthesis
-
Signal Transduction / drug effects*
-
Signal Transduction / immunology*
-
T-Lymphocytes / drug effects*
-
T-Lymphocytes / enzymology*
-
T-Lymphocytes / metabolism
Substances
-
Adjuvants, Immunologic
-
Fatty Acids, Unsaturated
-
Immunosuppressive Agents
-
Interleukin-13
-
Interleukin-2
-
NF-kappa B
-
Protein Subunits
-
Receptors, Interleukin-2
-
JNK Mitogen-Activated Protein Kinases
-
Mitogen-Activated Protein Kinases